Using QALYs in Cancer: A Review of the Methodological Limitations

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.8, 2011-08, pp. : 673-685

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost of Lung Cancer: A Methodological Review

By Molinier Laurent

PharmacoEconomics, Vol. 24, Iss. 7, 2006-01 ,pp. : 651-659

Adis International

Access to resources Recommend Favorite

QALYs and Carers

By Al-Janabi Hareth

PharmacoEconomics, Vol. 29, Iss. 12, 2011-12 ,pp. : 1015-1023

Adis International

Access to resources Recommend Favorite

Critical Review of the Evidence on 5-Aminosalicilate for Chemoprevention of Colorectal Cancer in Ulcerative Colitis: A Methodological Question

Current Clinical Pharmacology, Vol. 9, Iss. 1, 2014-02 ,pp. : 84-90

Bentham Science Publishers

Access to resources Recommend Favorite

The Value of Thinly Spread QALYs

By Mortimer Duncan

PharmacoEconomics, Vol. 24, Iss. 9, 2006-01 ,pp. : 845-853

Adis International

Access to resources Recommend Favorite

The Cost of Dementia in Europe: A Review of the Evidence, and Methodological Considerations

By Jönsson Linus

PharmacoEconomics, Vol. 27, Iss. 5, 2009-05 ,pp. : 391-403

Adis International

Access to resources Recommend Favorite